Navigation Links
'Daronrix', Glaxo's Bird-flu Vaccine Approved by European Medicines Agency

London – 'Daronrix', Glaxo's bird-flu vaccine, will hold a pride of place in the annals of preventive medicine, to be the first experimental bird-flu //vaccine to receive certification by the European Medicines Agency, for its use in protecting people in the event of a bird-flu pandemic.

This first generation vaccine can be used only after the WHO or the European Union officially declares a pandemic.

A second –generation vaccine has also been conceived by the same company, Glaxo, and work is underway to study the effects of the vaccine in combating the H5N1 virus strain. The product is slated to go in for approval in the subsequent weeks. This second generation vaccine is intended to strengthen the immune system, as a preventive measure against an imminent pandemic.

The vaccine is doubly beneficial as it has been developed necessitating lesser quantity of antigen to elicit a powerful immune response, which will allow the production of the vaccine in huge quantities, especially beneficial during mass vaccination programmes.
SA
'"/>




Page: 1

Related medicine news :

1. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
2. H5N1 Bird-flu Confirmed in France
3. Hungry for respite: Bird-flu virus ruffles poultry in Hungary
4. Intelligent Ways to Prevent a Bird-flu Outbreak
5. Thai’s Health Ministry Stocked To Deal With Any Possible Bird-flu Outbrea
6. Bird-flu Vaccine Adjuvant Contract Goes to Novartis
7. Vaccine to quit smoking?
8. First Vaccine Designed for Africa Cleared for Testing in Humans
9. Vaccine for Alzheimer’s diseas
10. Health Officials Recommend Flu Vaccine
11. Smallpox Vaccine May Help Fight Cervical Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... ... February 22, 2017 , ... VitreosHealth ... each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as gaps-in-care ... transform the HCC Risk Adjustment process from a typical fragmented process to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the World Horse Expo ... Tom Seay and his production crew. Tom Seay’s program “Best of America by ... Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, the ...
(Date:2/22/2017)... ... February 22, 2017 , ... ANGLESTRONG , the new recovery ... available on the App Store and Google Play . Florida-based Sober ... addiction and recovery industry, partnered with Angle to build ANGLESTRONG. The new recovery management ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... A product ... people seem to derive a heart-protective benefit from eating soy foods, while others do ... Japanese men who are able to produce equol—a substance made by some types of ...
(Date:2/22/2017)... ... February 22, 2017 , ... Super-Sod will attend the Athens ... in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home Show booth of ... the booth, grass seed plant manager Chris Roquemore constructed furniture from recycled pallet wood ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... VIEW, Calif. , Feb. 22, 2017 ... that it will release financial results for the fourth ... Wednesday, March 8, 2017.  The Company,s management team will ... PT / 5:00 p.m. ET. Investors interested ... by dialing (844) 707-0665 for domestic callers or (703) ...
(Date:2/22/2017)... NEW YORK , Feb. 22, 2017 ... spinal cord partnering deals and agreements entered into by ... report: http://www.reportlinker.com/p03605680-summary/view-report.html Description The Global Spinal ... understanding and access to partnering deals and agreements entered ... - Trends in partnering deals - Top deals ...
(Date:2/22/2017)... NEW YORK , Feb. 22, 2017 /PRNewswire/ ... to the congestive heart failure partnering deals and ... companies. Read the full report: http://www.reportlinker.com/p03605673-summary/view-report.html ... Partnering since 2010 report provides understanding and access ... the world,s leading healthcare companies. - ...
Breaking Medicine Technology: